Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. Contralateral leg after a first unprovoked deep vein thrombosis

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 6, 2012, Pages 1036-1042

  Galanaud, J P ^a   Holcroft, C A ^a   Rodger, M A ^b,c   Kovacs, M J ^d   Betancourt, M T ^b,c   Wells, P S ^b,c   Anderson, D R ^e   Chagnon, I ^f   Le Gal, G ^g   Solymoss, S ^a,h   Crowther, M A ⁱ   Perrier, A ^j   White, R H ^k   Vickars, L M ^l   Ramsay, T ^b,c   Kahn, S R ^a,h  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^g UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^h MCGILL UNIVERSITY   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Chronic venous disorders; Deep vein thrombosis; Post thrombotic syndrome; Venous insufficiency; Venous thromboembolism; Villalta scale

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTRALATERAL LEG; FEMALE; HUMAN; IPSILATERAL LEG; LEG; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; VILLALTA SCORE;

ADULT; AGED; ANTICOAGULANTS; CANADA; DECISION SUPPORT TECHNIQUES; FEMALE; FRANCE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; POSTTHROMBOTIC SYNDROME; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TIME FACTORS; UNITED STATES; VENOUS THROMBOSIS;

EID: 84861699880     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04713.x     Document Type: Article

References (28)

1. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879-83.
2. Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009; 145: 286-95.
3. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
4. Guanella R, Johri M, Miron M-J, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Ginsberg JS, Lamping DL, Shrier I, Kahn SR. Economic burden and cost determinants of deep venous thrombosis during two years following diagnosis: a prospective evaluation. J Thromb Haemost 2011; 9: 2397-405.
5. Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Ginsberg JS. Determinants of health-related quality of life during the 2years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105-12.
6. Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 2011; 124: 756-65.
7. Musani MH, Matta F, Yaekoub AY, Liang J, Hull RD, Stein PD. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med 2010; 123: 735-40.
8. Villalta SBP, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis 1994; 24: 158a.
9. Kahn SR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost 2009; 7: 884-8.
10. Rodger MA, Kahn SR, Le Gal G, Solymoss S, Chagnon I, Anderson DR, Wells PS, Kovacs MJ. Inter-observer reliability of measures to assess the post-thrombotic syndrome. Thromb Haemost 2008; 100: 164-6.
11. O'Donnell MJ, McRae S, Kahn SR, Julian JA, Kearon C, Mackinnon B, Magier D, Strulovich C, Lyons T, Robinson S, Hirsh J, Ginsberg JS. Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial. Thromb Haemost 2008; 99: 623-9.
12. Kahn SR, Ducruet T, Lamping DL, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Shrier I. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med 2005; 165: 1173-8.
13. Kahn SR. How I treat postthrombotic syndrome. Blood 2009; 114: 4624-31.
14. Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009; 28: 465-76.
15. Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicentre cross-sectional study in 40, 095 patients. Phlebology 2003; 18: 110-22.
16. Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, Golomb BA. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003; 158: 448-56.
17. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 179: 417-26.
18. Dumont WD, Plummer WD. Power and sample size program available for free on the Internet. Control Clin Trials 1997; 274.
19. Meissner MH, Eklof B, Lohr JM, Lurie F, Kistner R, Wakefield TW. Preface: acute and chronic venous disease. Current status and future directions. J Vasc Surg 2007; 46(Suppl S): 1S-3S.
20. Kolbach DN, Neumann HA, Prins MH. Definition of the post-thrombotic syndrome, differences between existing classifications. Eur J Vasc Endovasc Surg 2005; 30: 404-14.
21. Kahn SR, Kearon C, Julian JA, MacKinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005; 3: 718-23.
22. Heit JA, Rooke TW, Silverstein MD, Mohr DN, Lohse CM, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg 2001; 33: 1022-7.
23. Meissner MH, Eklof B, Smith PC, Dalsing MC, DePalma RG, Gloviczki P, Moneta G, Neglen P, T OD, Partsch H, Raju S. Secondary chronic venous disorders. J Vasc Surg 2007; 46(Suppl S): 68S-83S.
24. Ashrani AA, Silverstein MD, Lahr BD, Petterson TM, Bailey KR, Melton LJ, Heit JA. Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med 2009; 14: 339-49.
25. Tick LW, Kramer MH, Rosendaal FR, Faber WR, Doggen CJ. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008; 6: 2075-81.
26. Rance A, Emmerich J, Guedj C, Fiessinger JN. Occult cancer in patients with bilateral deep vein thrombosis. Lancet 1997; 350: 1448-9.
27. Mohr DN, Silverstein MD, Heit JA, Petterson TM, O'Fallon WM, Melton LJ. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc 2000; 75: 1249-56.
28. Langer RD, Ho E, Denenberg JO, Fronek A, Allison M, Criqui MH. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med 2005; 165: 1420-4.